Clinical Trial

AvertD Post-Approval Study

Recruiting
View on ClinicalTrials.gov →
Summary
A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population
Trial Details
NCT Number NCT07135323
Lead Sponsor Prescient Medicine Holdings, Inc.
Collaborators: Caron Treatment Centers, Concentrics Research
Conditions Opioid Use Disorder
Enrollment 4,000 participants
Start Date 2024-11-15
Primary Completion 2031-11 (estimated)
Study Completion 2031-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-22